(Total Views: 438)
Posted On: 01/09/2022 4:11:35 PM
Post# of 145254
Trodelvy sales for the third quarter of 2021 were $101 Million.
Veklury sales were $1.9 Billion for the same time period.
The current survival rate "there are many" should be made known...ASAP. SAFETY is first...on the agenda for the FDA...then efficacy. OURS is a better drug...as demonstrated by the times "alive." The Substantial difference alluded by the FDA... should only be seen through the "eyes" of the suffering.
Adulhelm anyone???
Veklury sales were $1.9 Billion for the same time period.
The current survival rate "there are many" should be made known...ASAP. SAFETY is first...on the agenda for the FDA...then efficacy. OURS is a better drug...as demonstrated by the times "alive." The Substantial difference alluded by the FDA... should only be seen through the "eyes" of the suffering.
Adulhelm anyone???
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)